This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (552) Obstetrics, Gynecology, and Reproductive Medicine (243) Pregnancy Information, Education and Lifestyle Interventions (308)

Published on in Vol 11, No 10 (2022): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/37452, first published .
The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial

The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial

The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial

Authors of this article:

Pablo Garcia-Manau1 Author Orcid Image ;   Manel Mendoza1 Author Orcid Image ;   Erika Bonacina1 Author Orcid Image ;   Raquel Martin-Alonso2, 3 Author Orcid Image ;   Lourdes Martin4 Author Orcid Image ;   Ana Palacios5, 6 Author Orcid Image ;   Maria Luisa Sanchez7 Author Orcid Image ;   Cristina Lesmes8 Author Orcid Image ;   Ivan Hurtado9 Author Orcid Image ;   Esther Perez10 Author Orcid Image ;   Albert Tubau11 Author Orcid Image ;   Patricia Ibañez12 Author Orcid Image ;   Marina Alcoz13 Author Orcid Image ;   Nuria Valiño14 Author Orcid Image ;   Elena Moreno15 Author Orcid Image ;   Carlota Borrero16 Author Orcid Image ;   Esperanza Garcia17 Author Orcid Image ;   Eva Lopez-Quesada18 Author Orcid Image ;   Sonia Diaz19 Author Orcid Image ;   Jose Roman Broullon20 Author Orcid Image ;   Mireia Teixidor21 Author Orcid Image ;   Carolina Chulilla22 Author Orcid Image ;   Maria M Gil2, 3 Author Orcid Image ;   Monica Lopez4 Author Orcid Image ;   Amparo Candela-Hidalgo5, 6 Author Orcid Image ;   Andrea Salinas-Amoros7 Author Orcid Image ;   Anna Moreno8 Author Orcid Image ;   Francesca Morra9 Author Orcid Image ;   Oscar Vaquerizo10 Author Orcid Image ;   Beatriz Soriano11 Author Orcid Image ;   Marta Fabre12 Author Orcid Image ;   Elena Gomez-Valencia13 Author Orcid Image ;   Ana Cuiña14 Author Orcid Image ;   Nicolas Alayon15 Author Orcid Image ;   Jose Antonio Sainz16 Author Orcid Image ;   Angels Vives17 Author Orcid Image ;   Esther Esteve18 Author Orcid Image ;   Vanesa Ocaña19 Author Orcid Image ;   Miguel Ángel López20 Author Orcid Image ;   Anna Maroto21 Author Orcid Image ;   Elena Carreras1 Author Orcid Image
Article Authors Cited by (4) Tweetations (8) Metrics

Journals

  1. Deinichenko O, Sіusіuka V, Krut’ Y, Pavlyuchenko M, Puchkov V, Shevchenko A, Kolokot N. Clinical and pathogenetic mechanisms of formation of fetal growth retardation. Reproductive health of woman 2023;(3):24 View
  2. Palmrich P, Kalafat E, Pateisky P, Schirwani‐Hartl N, Haberl C, Herrmann C, Khalil A, Binder J. Prognostic value of angiogenic markers in pregnancy with fetal growth restriction. Ultrasound in Obstetrics & Gynecology 2024;63(5):619 View
  3. Ramirez Zegarra R, Ghi T, Lees C. Does the use of angiogenic biomarkers for the management of preeclampsia and fetal growth restriction improve outcomes?: Challenging the current status quo. European Journal of Obstetrics & Gynecology and Reproductive Biology 2024;300:268 View
  4. Garcia-Manau P, Bonacina E, Martin-Alonso R, Martin L, Palacios A, Sanchez-Camps M, Lesmes C, Hurtado I, Perez E, Tubau A, Ibañez P, Alcoz M, Valiño N, Moreno E, Borrero C, Garcia E, Lopez-Quesada E, Diaz S, Broullon J, Teixidor M, Chulilla C, Ferrer-Costa R, Gil M, Lopez M, Ramos-Forner G, Blanco J, Moreno A, Lázaro-Rodríguez M, Vaquerizo O, Soriano B, Fabre M, Gomez-Valencia E, Cuiña A, Alayon N, Sainz-Bueno J, Vives A, Esteve E, Ocaña V, López M, Maroto A, Carreras E, Mendoza M. Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trial. Nature Medicine 2025 View